Comparing JC virus DNA detection by PCR with JC virus antibody testing to identify natalizumab-treated patients previously exposed to JC virus

被引：0
|
作者：
Kinsella, K.
Kelly, S. B.
De Gascun, C. F.
Carr, M.
Duggan, M.
Hutchinson, M.
Tubridy, N.
McGuigan, C.
机构：
[1] St Vincents Univ Hosp, Dublin 4, Ireland
[2] UCD, Natl Virus Ref Lab, Dublin, Ireland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P533
引用
收藏
页码：S230 / S230
页数：1
相关论文
共 50 条
  • [31] Prevalence of anti-JC virus antibodies in a cohort of 1'200 natalizumab-treated MS patients
    Radji, F.
    Outteryck, O.
    Zephir, H.
    Ongagna, J. C.
    Brochet, B.
    Ouallet, J. C.
    Rumbach, L.
    Lebrun-Frenay, C.
    Debouverie, M.
    Pittion, S.
    Laplaud, D.
    Wiertlewski, S.
    Cabre, P.
    Confavreux, C.
    Vukusic, S.
    Pelletier, J.
    Audouin, B.
    Defer, G.
    Derache, N.
    Camu, W.
    Thouvenot, E.
    Tourbah, A.
    Labauge, P.
    Moreau, T.
    Fromont, A.
    Castelnovo, G.
    Clavelou, P.
    Casez, O.
    Hautecoeur, P.
    Papeix, C.
    Couturier, N.
    Viala, F.
    Liblau, R.
    Clanet, M.
    De Seze, J.
    Vermersch, P.
    Brassat, D.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S216 - S216
  • [32] CD34+hematopoietic progenitor cells are a reservoir for JC Virus in natalizumab-treated MS patients
    Monaco, Maria Chiara
    Ryschkewitsch, Caroline
    Jensen, Peter N.
    Johnson, Kory
    Major, Eugene O.
    JOURNAL OF NEUROVIROLOGY, 2012, 18 : 73 - 73
  • [33] Study of the JC virus presence in multiple sclerosis patients treated with natalizumab
    Dominguez-Mozo, M. I.
    Garcia-Montojo, M.
    De las Heras, V.
    Garcia-Martinez, M. A.
    Arias-Leal, A.
    Casanova, I.
    Alvarez-Lafuente, R.
    Arroyo, R.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 370 - 371
  • [34] Systematic Assessment of JC Virus in Multiple Sclerosis Patients Treated with Natalizumab
    Slesari, Iuliana
    Heinzlef, Olivier
    Poveda, Jean-Dominique
    NEUROLOGY, 2010, 74 (09) : A369 - A369
  • [35] Systemic assessment of JC virus in multiple sclerosis patients treated with natalizumab
    Slesari, I.
    Manzouni, T.
    Brugeilles, H.
    Romatet, S.
    Chamouard, J.
    Poveda, J. D.
    Heinzlef, O.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S120 - S120
  • [36] Systematic assessment of JC virus in multiple sclerosis patients treated with natalizumab
    Slesari, I.
    Heinzlef, O.
    Poveda, J. -D.
    JOURNAL OF NEUROLOGY, 2010, 257 : S220 - S220
  • [37] Therapeutic Decision after JC Virus Testing in a Cohort of Patient Treated with Natalizumab
    Ongagna, Jean-Claude
    Fleury, Marie-Celine
    Collongues, Nicolas
    Blanc, Frederic
    de Seze, Jerome
    NEUROLOGY, 2013, 80
  • [38] Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort
    Trampe, A. K.
    Hemmelmann, C.
    Stroet, A.
    Haghikia, A.
    Hellwig, K.
    Wiendl, H.
    Goelz, S.
    Ziegler, A.
    Gold, R.
    Chan, A.
    NEUROLOGY, 2012, 78 (22) : 1736 - 1742
  • [39] Anti-JC Virus Antibodies in a Large German Natalizumab-Treated Multiple Sclerosis Cohort
    Chan, Andrew
    Trampe, Anne-Kathrin
    Hemmelmann, Claudia
    Stroet, Anke
    Haghikia, Aiden
    Hellwig, Kerstin
    Wiendl, Heinz
    Goelz, Susan
    Ziegler, Andreas
    Gold, Ralf
    NEUROLOGY, 2012, 78
  • [40] Effects of Natalizumab on JC Virus Antibody Titers Over Time
    Dobrowolski, Jakob
    Williamson, Eric
    ANNALS OF NEUROLOGY, 2017, 82 : S188 - S189
12345